Management tracks

RNA therapeutics company Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) said SVP and CBO David-Alexandre Gros will resign for personal reasons, effective Jan. 6. The company is searching for

Read the full 267 word article

User Sign In